Celularity, Inc. (CELU)
1.855
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 16:00
1.83
-0.02
(-1.35%)
After-Hours: 20:00
Celularity Cash from Investing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -1.556M |
| September 30, 2024 | -0.035M |
| June 30, 2024 | 2.144M |
| March 31, 2024 | -0.039M |
| December 31, 2023 | -0.58M |
| September 30, 2023 | -0.228M |
| June 30, 2023 | -0.031M |
| March 31, 2023 | -3.209M |
| December 31, 2022 | -0.779M |
| September 30, 2022 | -1.563M |
| Date | Value |
|---|---|
| June 30, 2022 | -1.44M |
| March 31, 2022 | -1.454M |
| December 31, 2021 | -2.303M |
| September 30, 2021 | -1.113M |
| June 30, 2021 | -1.008M |
| March 31, 2021 | -1.479M |
| December 31, 2020 | -9.372M |
| September 30, 2020 | -4.017M |
| June 30, 2020 | 0.4362M |
| March 31, 2020 | 0.1375M |
| December 31, 2019 | 0.116M |
| September 30, 2019 | 0.535M |
| June 30, 2019 | -287.50M |
| March 31, 2019 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 0.00 |
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | 0.00 |
| Century Therapeutics, Inc. | 17.77M |
| Absci Corp. | 24.07M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.103M |
| Cash from Financing (Quarterly) | 11.22M |
| Free Cash Flow | -13.25M |
| Free Cash Flow Per Share (Quarterly) | -0.177 |
| Free Cash Flow to Equity (Quarterly) | -13.05M |
| Free Cash Flow to Firm (Quarterly) | -4.206M |
| Free Cash Flow Yield | -27.82% |